View Article

Abstract

Polyendocrine metabolic ovarian syndrome (PMOS), recently proposed as the new name for polycystic ovary syndrome (PCOS), is a common hormonal and metabolic disorder of women of reproductive age, characterised by irregular ovulation, raised androgens and insulin resistance. Since its treatment is long-term and the drugs have side effects, many women use herbal supplements for supportive care, but powders and capsules are bitter and unpalatable. A gummy is a soft, chewable and pleasant-tasting dosage form that can carry herbal ingredients in a sugar-free gel matrix. Cinnamon, guduchi, fenugreek and linseed are easily available food-grade herbs with reported effects on insulin sensitivity, glucose and lipid levels and oxidative stress. This review discusses PMOS, the concept, advantages, limitations and composition of herbal gummies, the profile of the four herbs and the main excipients, the methods of preparation, the gelling agents, the factors affecting quality and the parameters used for evaluation, with the important reports on the subject.

Keywords

PMOS, PCOS, Herbal gummy, Cinnamon, Guduchi, Fenugreek, Linseed, Nutraceutical

Introduction

× Popup Image

Polycystic ovary syndrome (PCOS) is one of the commonest endocrine disorders of women of reproductive age. It is characterised by irregular ovulation, raised androgen levels (acne, excess hair growth, hair loss) and, in most patients, insulin resistance, with weight gain and a higher risk of type 2 diabetes, dyslipidaemia and cardiovascular disease[1,2,3]. An international consensus process in 2026 has renamed it polyendocrine metabolic ovarian syndrome (PMOS), because the condition involves many hormonal and metabolic systems and not only the ovaries; many affected women do not have cysts at all.

The management of PMOS is long-term and includes lifestyle changes together with drugs such as oral contraceptives, metformin and anti-androgens, chosen according to the symptoms[3]. Since the disorder is chronic and the drugs have side effects, many women use nutritional supplements and herbal products as a supportive measure[4,5,6]. A supportive supplement should act on insulin sensitivity, glucose and lipid levels and oxidative stress.

Herbal powders, capsules and tablets are bitter, bulky and unpalatable, so regular intake over months is poor. A gummy is a soft, chewable, gel-type dosage form, which can carry herbal ingredients in a pleasant-tasting matrix and is readily accepted by adults and adolescents. Cinnamon, guduchi, fenugreek and linseed are cheap, easily available, food-grade herbs with reported effects on insulin sensitivity, glucose and lipids, and a sugar-free herbal gummy of these herbs is therefore a useful and practical option for supportive use in PMOS[7,8,9,10,11].

figure

Figure 1: Components of a Herbal Nutraceutical Gummy

Polyendocrine Metabolic Ovarian Syndrome (PMOS)

The syndrome is diagnosed by hyperandrogenism (clinical or biochemical) together with ovarian dysfunction (irregular ovulation or polycystic ovaries), after other related disorders are excluded[1,12]. Insulin resistance and the resulting high insulin levels stimulate the ovaries to make more androgens, and they also lead to weight gain, abnormal lipids and an increased risk of diabetes. Oxidative stress and low-grade inflammation are also present[13,14]. Lifestyle change, with diet and exercise, remains the first line of treatment, and supportive nutritional measures aim at improving the metabolic features[3,12].

Concept of Herbal Nutraceutical Gummy

A gummy is usually made with gelatin or pectin as the gelling agent, together with sweeteners, a humectant, an acid and a flavour. The herbal powders or extracts are dispersed in the gel matrix, and the mass is poured into moulds and set by cooling[15,16]. In the present approach a sugar-free base of sorbitol, xylitol and glycerin is used, since a high sugar intake is not desirable in women with insulin resistance. The gummy is meant as a supportive nutritional supplement and not as a substitute for medical treatment.

Advantages of Herbal Nutraceutical Gummies

  • The pleasant taste and chewable texture improve acceptance and compliance for long-term use.
  • No water is needed, and the bitterness of the herbs is masked by the sweeteners and the flavour.
  • Each piece contains a measured and uniform dose, unlike loose powders.
  • They can be made on a small scale with simple equipment.
  • A sugar-free base is possible, which suits women with insulin resistance.

Limitations of Gummies

  • Gelatin of animal origin is not acceptable to vegetarians; pectin or agar can be used instead.
  • They are sensitive to heat and humidity, which make them sticky, so proper packing is needed.
  • The amount of herbal powder per piece is limited, because a high load changes the texture.
  • Polyols such as sorbitol may cause a laxative effect when taken in high amounts.
  • Herbal materials differ in composition, so standardisation is needed.

Characteristics of an Ideal Herbal Gummy

  • Uniform, smooth and elastic texture, which is chewable but not too hard or sticky.
  • Uniform weight and content of the herbal ingredients in every piece.
  • Acceptable taste, colour and odour, with the herbal bitterness masked.
  • Low moisture content and good physical, chemical and microbial stability during storage.
  • Safe, with food-grade ingredients and a sugar-free base.

Composition of Gummy

The usual components of a gelatin gummy are given in the table below[15,16,17].

Table: General Composition of a Herbal Gummy

Sr. No. Component Typical amount Examples
1 Active (herbal) ingredient 5 – 30% w/w Herbal powders, extracts, vitamins, minerals
2 Gelling agent 5 – 15% w/w Gelatin, pectin, agar, carrageenan, modified starch
3 Sweetener / bulking agent 20 – 50% w/w Sorbitol, xylitol, maltitol, sucrose, glucose syrup
4 Humectant 5 – 15% w/w Glycerin, propylene glycol
5 Acidulant / buffer 0.5 – 2% w/w Citric acid, sodium citrate
6 Flavour and colour 0.1 – 1% w/w Orange, lemon or berry flavour; natural colours
7 Solvent q.s. Purified water

Profile of Herbs and Excipients

The four herbs are described below. They are easily available in India, have a long history of food and traditional use, and have been studied for effects relevant to PMOS[7,18,19,20].

Cinnamon (Cinnamomum verum)

Table: Profile of Cinnamon

Sr. No. Parameter Details
1 Botanical name Cinnamomum verum J. Presl (syn. C. zeylanicum Blume)
2 Family Lauraceae
3 Common names Cinnamon, Dalchini (Hindi), Tvak (Sanskrit)
4 Part used Dried inner bark
5 Major constituents Cinnamaldehyde (main constituent of the bark oil), eugenol, polyphenols, tannins, mucilage
6 Reported activities Improves insulin sensitivity, lowers fasting glucose, antioxidant, anti-inflammatory
7 Traditional uses Digestive, carminative, flavouring and for diabetes and cold

Cinnamon has been shown in meta-analyses to lower fasting plasma glucose in type 2 diabetes, and it has been studied for the metabolic parameters of PCOS. It is generally well tolerated at the usual doses, although the coumarin content of the cheaper cassia types should be remembered[7,8,9,21].

Guduchi (Tinospora cordifolia)

Table: Profile of Guduchi

Sr. No. Parameter Details
1 Botanical name Tinospora cordifolia (Willd.) Miers
2 Family Menispermaceae
3 Common names Guduchi, Giloy (Hindi), Amrita (Sanskrit)
4 Part used Dried stem
5 Major constituents Berberine, palmatine, diterpenoid lactones, glycosides, polysaccharides
6 Reported activities Hypoglycaemic, immunomodulatory, antioxidant, adaptogenic
7 Traditional uses Fever, diabetes, general debility and as a rejuvenating tonic

Guduchi is widely used in Ayurveda, and its stem is reported to have blood-glucose lowering and antioxidant activity. It may add to the effect of antidiabetic drugs, so caution is advised in patients on such treatment[18,22].

Fenugreek (Trigonella foenum-graecum)

Table: Profile of Fenugreek

Sr. No. Parameter Details
1 Botanical name Trigonella foenum-graecum Linn.
2 Family Fabaceae
3 Common names Fenugreek, Methi (Hindi), Methika (Sanskrit)
4 Part used Dried ripe seeds
5 Major constituents Galactomannan fibre, saponins (diosgenin), 4-hydroxyisoleucine, trigonelline, alkaloids
6 Reported activities Antidiabetic, lipid-lowering, galactagogue
7 Traditional uses Digestive, diabetes, lactation aid and flavouring

The soluble fibre of fenugreek slows the absorption of glucose, and 4-hydroxyisoleucine is reported to increase insulin secretion. Gas and loose stools may occur in some persons[19,22].

Linseed (Linum usitatissimum)

Table: Profile of Linseed

Sr. No. Parameter Details
1 Botanical name Linum usitatissimum Linn.
2 Family Linaceae
3 Common names Linseed, Flaxseed, Alsi (Hindi), Atasi (Sanskrit)
4 Part used Dried ripe seeds
5 Major constituents α-Linolenic acid (omega-3 fatty acid), lignans, mucilage, dietary fibre, proteins
6 Reported activities Lipid lowering, phytoestrogenic, improves glycaemic control
7 Traditional uses Laxative, demulcent, and as a food and oil source

Flaxseed supplementation has been studied in women with PCOS, and its fibre, lignans and omega-3 fatty acid content are considered useful for the metabolic and hormonal features[10,11,20].

Role of Gelatin, Polyols and Glycerin

Gelatin is a protein obtained from collagen, and forms a thermoreversible, elastic gel on cooling, which gives the gummy its chewy texture; the strength of the gel is expressed as its Bloom value[15,16]. Sorbitol and xylitol are sugar alcohols that provide sweetness and bulk without raising blood glucose much, and glycerin is a humectant that keeps the gummy soft and prevents it from drying[15]. Citric acid adjusts the pH and gives a pleasant sour taste.

Methods of Preparation and Related Aspects

Gummies are prepared by confectionery methods adapted for nutraceuticals. The common methods are described below[15,16,17].

A. Methods of Preparation of Gummies

1. Moulding (cast and set) method: this is the simplest method and is suitable for small batches. The gelling agent is swollen and melted, the sweeteners and humectant are added, and the herbal ingredients are added after cooling to about 55 to 60 °C, so as to protect heat-sensitive constituents. The mass is poured into moulds, set in a refrigerator, demoulded and cured[15,17].

2. Starch mogul method: the mass is deposited into impressions made in trays of dry starch, and dried for a long time in a drying room. It is used for large-scale production and needs a special unit[17].

3. Depositing in moulds: a depositor fills the hot mass into moulds without starch. It gives clean products but the equipment is costly[17].

4. Extrusion: the mass is mixed and forced through an extruder and cut into pieces. The method is continuous but uses a high temperature, which may damage herbal constituents[17].

figure

Figure 2: Moulding Method for Preparation of Herbal Gummy

Table: Comparison of Methods of Preparation of Gummies

Sr. No. Method Main requirement Remarks
1 Moulding (cast and set) Silicone moulds, hot plate Simple, low cost; suitable for small batches
2 Starch mogul Starch trays, drying room Large scale; long drying, special unit
3 Depositing in moulds Depositor, moulds No starch, clean; costly equipment
4 Extrusion Extruder, cutter Continuous; high temperature
5 Cold-set Cooling control Protects heat-sensitive herbs

B. Gelling Agents Used for Gummies

Table: Commonly Used Gelling Agents

Sr. No. Gelling agent Important features
1 Gelatin Animal protein; elastic, chewy, thermoreversible gel; not suitable for vegetarians
2 Pectin Plant polysaccharide; needs sugar and acid to gel; vegetarian; shorter texture
3 Agar Seaweed polysaccharide; firm, brittle gel; vegetarian; high setting temperature
4 Carrageenan Seaweed polysaccharide; gels with potassium ions; used in combinations
5 Modified starch Gives a soft gel; used in starch mogul production

C. Factors Affecting the Quality of Gummies

The gelatin concentration decides the hardness and chewiness; too little gives a soft and sticky gummy, whereas too much gives a hard, rubbery one. The temperature of the mass is important, because gelatin loses its gelling power on prolonged heating and the herbal constituents may be damaged at high temperature. The herbal load affects the texture, as high amounts of powder and fibre make the gummy hard and grainy. The humectant and water content control the softness and the stickiness, and the curing and drying time and the packing decide the moisture and stability during storage, so that airtight, light-proof containers with silica gel are preferred[16,17].

Evaluation Parameters

A herbal gummy is evaluated for its physical properties, its chemical and antioxidant properties, its sensory acceptance, its microbial quality and its stability. The main parameters and the criteria generally expected are summarised in the table below.

Table: Evaluation Parameters and Expected Criteria

Sr. No. Parameter Method / instrument Expected criteria
1 Appearance Visual inspection Uniform colour, smooth surface, no air bubbles
2 Weight variation Weigh 20 gummies individually Within ± 5% of the average
3 Texture (hardness) Texture analyser or penetrometer Chewy, not too hard or sticky
4 pH pH meter, 10% dispersion Acceptable, mildly acidic
5 Moisture content Drying at 105 °C to constant weight Low and uniform
6 Dissolution (dispersion) time Gummy in 100 mL buffer pH 6.8 at 37 °C, 50 rpm Disperses in a reasonable time
7 Total phenolic content Folin–Ciocalteu method, gallic acid standard[23,24] Consistent with herbal load
8 DPPH radical scavenging DPPH assay, 517 nm, ascorbic acid standard[25] Dose-dependent scavenging
9 α-Amylase inhibition DNSA method, 540 nm, acarbose standard[26] Dose-dependent inhibition
10 Sensory evaluation 9-point hedonic scale, after ethics approval and consent Good acceptance for taste and texture
11 Microbial load Plate count; tests for E. coli and Salmonella Within limits; pathogens absent
12 Stability 25 °C / 60% RH and 40 °C / 75% RH[27] No change in appearance, texture or content

Review of Literature

Azziz et al. (2009) reviewed the evidence on the syndrome and proposed diagnostic criteria based on hyperandrogenism together with ovarian dysfunction, and Teede et al. (2011, 2018, 2023) published the international evidence-based guidelines for the assessment and management of PCOS, with emphasis on lifestyle intervention and multidisciplinary care[1,3,12,28]. Legro et al. (2013) gave the Endocrine Society guideline for its diagnosis and treatment, and Azziz et al. (2016) described the mechanisms, with the role of insulin resistance and hyperandrogenism[2,13].

Allen et al. (2013) carried out an updated meta-analysis of cinnamon use in type 2 diabetes and reported its effect on fasting plasma glucose, and Ranasinghe et al. (2013) reviewed the medicinal properties of true cinnamon, including antioxidant, antidiabetic and lipid-lowering activities[7,8]. Heydarpour et al. (2020) and Maleki et al. (2021) reviewed the effects of cinnamon on the metabolic parameters of PCOS, including its action on insulin signalling[9,29].

Salehi et al. (2019) reviewed the antioxidant and anti-inflammatory properties of cinnamon, and Hajimonfarednejad et al. (2019) found in a review of adverse events that it is generally well tolerated at the usual doses[14,21]. Ríos et al. (2015) reviewed the natural products studied for type 2 diabetes, and discussed their possible mechanisms of action on glucose metabolism[22].

Mohammadi-Sartang et al. (2020) carried out a randomised controlled trial of flaxseed supplementation on the metabolic status of women with PCOS, Emamat et al. (2023) reviewed the clinical trials of flaxseed or its oil in PCOS, and Nowak and Jeziorek (2023) described the role of flaxseed in human health, including its fibre, lignan and omega-3 content[10,11,20].

Arentz et al. (2017) reviewed the nutritional supplements and herbal medicines for women with PCOS and found possible benefits for some of them, but pointed out that the quality of the evidence was limited; Moini Jazani et al. (2019) and Dashti et al. (2026) reviewed the clinical studies and herbal compounds used in PCOS[4,5,6].

Djagny et al. (2001) reviewed gelatin as a protein for the food and pharmaceutical industries, and Delgado and Bañón (2015) studied the drying time of gummy confections on the basis of their mechanical properties, which shows the importance of the curing step in the quality of a gummy[16,17].

Research gap: cinnamon and linseed have been studied in PCOS, and guduchi and fenugreek are reported to improve glucose and lipid control, but these herbs have been tested separately, mostly as powders, capsules or extracts[9,10,18,19]. A combination of the four herbs in a palatable, sugar-free gummy has not been reported.

CONCLUSION AND FUTURE PERSPECTIVES

A herbal nutraceutical gummy is a simple and palatable way of giving herbal supplements over a long period. A sugar-free gummy of cinnamon, guduchi, fenugreek and linseed, prepared by the simple moulding method with gelatin, glycerin and polyols, could give a supportive product for women with PMOS, in whom insulin resistance, abnormal lipids and oxidative stress are the main problems. Such a product is intended as a supportive nutritional supplement and not as a replacement for medical treatment.

The quality of the gummy depends on the gelatin concentration, the temperature, the herbal load, the moisture content and the packing. More work is required on the standardisation of the herbal materials, the in vitro and in vivo activity, the safety of the combination, the sensory acceptance, the stability, and on clinical studies in women with PMOS.

REFERENCES

  1. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91 (2):456–488.
  2. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98 (12):4565–4592.
  3. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189 (2):G43–G64.
  4. Arentz S, Smith CA, Abbott J, Bensoussan A. Nutritional supplements and herbal medicines for women with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Complement Altern Med. 2017;17:500.
  5. Moini Jazani A, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, Nasimi Doost Azgomi R. A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). Daru. 2019;27 (2):863–877.
  6. Dashti S, Ashouri A, Bahri N. Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. J Ovarian Res. 2026;19:132.
  7. Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013;11 (5):452–459.
  8. Ranasinghe P, Pigera S, Premakumara GAS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of true cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med. 2013;13:275.
  9. Heydarpour F, Hemati N, Hadi A, Moradi S, Mohammadi E, Farzaei MH. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: a systematic review and meta-analysis. J Ethnopharmacol. 2020;254:112741.
  10. Mohammadi-Sartang M, Mazloom Z, Raeisi-Dehkordi H, Barati-Boldaji R, Bellissimo N, Totosy de Zepetnek JO. The effect of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial. Nutr J. 2020;19:8.
  11. Emamat H, Boushehri SN, Eslami MA, Saneei Totmaj A, Ghalandari H. The effects of flaxseed or its oil supplementations on polycystic ovary syndrome: a systematic review of clinical trials. Phytother Res. 2023;37 (3):1082–1091.
  12. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33 (9):1602–1618.
  13. Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
  14. Salehi B, Albayrak S, Antolak H, et al. Antioxidant and anti-inflammatory properties of cinnamon: a review of its potential effects on human health. Oxid Med Cell Longev. 2019;2019:1–14.
  15. Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2009.
  16. Djagny KB, Wang Z, Xu S. Gelatin: a valuable protein for food and pharmaceutical industries: review. Crit Rev Food Sci Nutr. 2001;41 (6):481–492.
  17. Delgado P, Bañón S. Determining the minimum drying time of gummy confections based on their mechanical properties. CyTA J Food. 2015;13 (3):329–335.
  18. Singh SS, Pandey SC, Srivastava S, Gupta VS, Patro B, Ghosh AC. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J Pharmacol. 2003;35:83–91.
  19. Yadav UCS, Baquer NZ. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol. 2014;52 (2):243–254.
  20. Nowak W, Jeziorek M. The role of flaxseed in improving human health. Healthcare. 2023;11 (3):395.
  21. Hajimonfarednejad M, Ostovar M, Raee MJ, Hashempur MH, Mayer JG, Heydari M. Cinnamon: a systematic review of adverse events. Clin Nutr. 2019;38 (2):594–602.
  22. Ríos JL, Francini F, Schinella GR. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 2015;81 (12–13):975–994.
  23. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16 (3):144–158.
  24. Kokate CK. Practical Pharmacognosy. 4th ed. New Delhi: Vallabh Prakashan; 1994.
  25. Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci Technol. 1995;28 (1):25–30.
  26. Bernfeld P. Amylases, alpha and beta. Methods Enzymol. 1955;1:149–158.
  27. International Council for Harmonisation. ICH Q1A (R2): Stability testing of new drug substances and products. Geneva: ICH; 2003.
  28. Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195 (6):S65–S112.
  29. Maleki V, Jafari-Vayghan H, Saleh-Ghadimi S, et al. Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review. J Ovarian Res. 2021;14:130.

Reference

  1. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91 (2):456–488.
  2. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98 (12):4565–4592.
  3. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189 (2):G43–G64.
  4. Arentz S, Smith CA, Abbott J, Bensoussan A. Nutritional supplements and herbal medicines for women with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Complement Altern Med. 2017;17:500.
  5. Moini Jazani A, Nasimi Doost Azgomi H, Nasimi Doost Azgomi A, Nasimi Doost Azgomi R. A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). Daru. 2019;27 (2):863–877.
  6. Dashti S, Ashouri A, Bahri N. Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. J Ovarian Res. 2026;19:132.
  7. Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013;11 (5):452–459.
  8. Ranasinghe P, Pigera S, Premakumara GAS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of true cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med. 2013;13:275.
  9. Heydarpour F, Hemati N, Hadi A, Moradi S, Mohammadi E, Farzaei MH. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: a systematic review and meta-analysis. J Ethnopharmacol. 2020;254:112741.
  10. Mohammadi-Sartang M, Mazloom Z, Raeisi-Dehkordi H, Barati-Boldaji R, Bellissimo N, Totosy de Zepetnek JO. The effect of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial. Nutr J. 2020;19:8.
  11. Emamat H, Boushehri SN, Eslami MA, Saneei Totmaj A, Ghalandari H. The effects of flaxseed or its oil supplementations on polycystic ovary syndrome: a systematic review of clinical trials. Phytother Res. 2023;37 (3):1082–1091.
  12. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33 (9):1602–1618.
  13. Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
  14. Salehi B, Albayrak S, Antolak H, et al. Antioxidant and anti-inflammatory properties of cinnamon: a review of its potential effects on human health. Oxid Med Cell Longev. 2019;2019:1–14.
  15. Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2009.
  16. Djagny KB, Wang Z, Xu S. Gelatin: a valuable protein for food and pharmaceutical industries: review. Crit Rev Food Sci Nutr. 2001;41 (6):481–492.
  17. Delgado P, Bañón S. Determining the minimum drying time of gummy confections based on their mechanical properties. CyTA J Food. 2015;13 (3):329–335.
  18. Singh SS, Pandey SC, Srivastava S, Gupta VS, Patro B, Ghosh AC. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J Pharmacol. 2003;35:83–91.
  19. Yadav UCS, Baquer NZ. Pharmacological effects of Trigonella foenum-graecum L. in health and disease. Pharm Biol. 2014;52 (2):243–254.
  20. Nowak W, Jeziorek M. The role of flaxseed in improving human health. Healthcare. 2023;11 (3):395.
  21. Hajimonfarednejad M, Ostovar M, Raee MJ, Hashempur MH, Mayer JG, Heydari M. Cinnamon: a systematic review of adverse events. Clin Nutr. 2019;38 (2):594–602.
  22. Ríos JL, Francini F, Schinella GR. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 2015;81 (12–13):975–994.
  23. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 1965;16 (3):144–158.
  24. Kokate CK. Practical Pharmacognosy. 4th ed. New Delhi: Vallabh Prakashan; 1994.
  25. Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci Technol. 1995;28 (1):25–30.
  26. Bernfeld P. Amylases, alpha and beta. Methods Enzymol. 1955;1:149–158.
  27. International Council for Harmonisation. ICH Q1A (R2): Stability testing of new drug substances and products. Geneva: ICH; 2003.
  28. Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195 (6):S65–S112.
  29. Maleki V, Jafari-Vayghan H, Saleh-Ghadimi S, et al. Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review. J Ovarian Res. 2021;14:130.

Photo
Samiksha Gavate
Corresponding author

UG Students, Anuradha College of Pharmacy, Chikhli, Maharashtra, India.

Photo
Sakshi Lokhande
Co-author

UG Students, Anuradha College of Pharmacy, Chikhli, Maharashtra, India.

Photo
Sakshi Mogarkar
Co-author

UG Students, Anuradha College of Pharmacy, Chikhli, Maharashtra, India.

Photo
Vaishnavi Kalekar
Co-author

UG Students, Anuradha College of Pharmacy, Chikhli, Maharashtra, India.

Photo
Vaishnavi Puri
Co-author

UG Students, Anuradha College of Pharmacy, Chikhli, Maharashtra, India.

Photo
Arati A. Patil
Co-author

Project Guide, Anuradha College of Pharmacy, Chikhli, Maharashtra, India.

Photo
R. H. Kale
Co-author

Principal, Anuradha College of Pharmacy, Chikhli, Maharashtra, India.

Samiksha Gavate, Sakshi Lokhande, Sakshi Mogarkar, Vaishnavi Kalekar, Vaishnavi Puri, Arati A. Patil, R. H. Kale, Herbal Nutraceutical Gummy of Cinnamon, Guduchi, Fenugreek and Linseed for Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Review, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 10, 3413-3420. https://doi.org/10.5281/zenodo.23622668

More related articles
Formulation and Evaluation of Murraya paniculata O...
Pradumn Pratap Singh , Pradeep Kumar...
A Comprehensive Review on the Phytochemical Consti...
Pradumn Pratap Singh , Pradeep Kumar...
Drug Utilization Patterns, Polypharmacy, And Adverse Drug Reactions Among Patien...
Riyad Hossain , Toufik Sarkar, Shyamal Nath, Deep Deb, Dhruva Narayan K., Abhisek Chaudhary...
Formulation And Evaluation Of An Antifungal Gel Containing Aloe Vera And Terbina...
Bhanunandana G.S., Dr. M. Mallikarjuna Gouda , Mahammad Shaz, Alan Joseph , Salman Paris, Shashank K...
Related Articles
Green Synthesis of Silver Nanoparticles Using Plant Extracts: A Review...
Mahesh Padghan, K. Biyani, Krushna Sharma, Manoj Dakhore, Kunal C. Khandeshe, Kshitij Shirsat, Rama...
Magnetic Herbal Nanoparticles For Targeted Drug Delivery And Biomedical Applicat...
Bhavika Vala, Nidhi Patel, Jahnvi Joshi, Anand Kumari captain ...